drugset / Trial / NCT05694130
Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
RandomizedParallel-groupOpen-labelTreatment
Summary
This 12-week randomized, open-label study evaluates the efficacy and safety of Tacrolimus combined with Glucocorticoid for Sjogren's syndrome patients with severe thrombocytopenia.
Timeline
- Start
- 2023-02
- Primary completion
- 2024-09
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 1 mg | Oral |
| Subject | Tacrolimus | Small molecule | 2 mg | Oral |
| Background | Prednisolone | Other / unclassified | 7.5 mg | Oral |